Agilent Technologies, Inc. $A Shares Sold by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 10.0% during the first quarter, HoldingsChannel reports. The firm owned 82,523 shares of the medical research company’s stock after selling 9,168 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Agilent Technologies were worth $9,406,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its holdings in Agilent Technologies by 57.2% in the 1st quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 108,174 shares of the medical research company’s stock worth $12,330,000 after acquiring an additional 39,350 shares during the period. Elevation Point Wealth Partners LLC acquired a new stake in Agilent Technologies in the first quarter valued at approximately $296,000. Keybank National Association OH raised its stake in shares of Agilent Technologies by 1.8% during the first quarter. Keybank National Association OH now owns 28,649 shares of the medical research company’s stock valued at $3,265,000 after purchasing an additional 496 shares during the period. KPP Advisory Services LLC raised its stake in shares of Agilent Technologies by 3.0% during the first quarter. KPP Advisory Services LLC now owns 4,279 shares of the medical research company’s stock valued at $488,000 after purchasing an additional 124 shares during the period. Finally, Root Financial Partners LLC lifted its position in shares of Agilent Technologies by 257.7% during the first quarter. Root Financial Partners LLC now owns 1,109 shares of the medical research company’s stock worth $126,000 after purchasing an additional 799 shares in the last quarter.

Agilent Technologies Stock Performance

Shares of A stock opened at $130.79 on Friday. The stock has a market capitalization of $36.94 billion, a price-to-earnings ratio of 26.26, a PEG ratio of 2.33 and a beta of 1.25. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The company’s 50-day simple moving average is $124.00 and its 200-day simple moving average is $125.98. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the company earned $1.31 earnings per share. Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is 20.48%.

Analyst Upgrades and Downgrades

A has been the subject of several analyst reports. Robert W. Baird upped their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price target for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. HSBC decreased their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Finally, Piper Sandler started coverage on Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $160.88.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.